These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 8771098)

  • 1. Clinical trials referral resource. Clinical trials with arsenic trioxide.
    Murgo AJ; McBee WL; Cheson BD
    Oncology (Williston Park); 2000 Feb; 14(2):206, 211, 215-6 passim. PubMed ID: 10736809
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cytostatic agents and cytostatic therapy].
    Host H
    Tidsskr Nor Laegeforen; 1973 Sep; 93(26):1857-62. PubMed ID: 4767918
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical trials referral resource. Clinical trials using bryostatin-1.
    Pluda JM; Cheson BD; Phillips PH
    Oncology (Williston Park); 1996 May; 10(5):740-2. PubMed ID: 8738829
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer chemotherapy.
    Smith LH
    Major Probl Intern Med; 1971; 1():1-197. PubMed ID: 5005758
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical trials. Referral resource. Clinical trials assessing quality of life.
    Cheson BD; McCabe MS; Phillips PH
    Oncology (Williston Park); 1995 Nov; 9(11):1171-4, 1176, 1178. PubMed ID: 8703685
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical trials referral resource. Clinical trials of suramin.
    Cheson BD; Phillips PH; Pluda JM; Christian M
    Oncology (Williston Park); 1995 Feb; 9(2):161, 163. PubMed ID: 8771098
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of hematologic malignancy].
    Shimoyama M
    Nihon Naika Gakkai Zasshi; 1996 Mar; 85(3):337-41. PubMed ID: 8690990
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro chemotherapy sensitivity testing for genitourinary malignancies.
    Lieber MM
    Prog Clin Biol Res; 1984; 153():51-65. PubMed ID: 6382286
    [No Abstract]   [Full Text] [Related]  

  • 9. Other chemotherapy regimens including mitoxantrone and suramin.
    Siu LL; Moore MJ
    Semin Urol Oncol; 1997 Feb; 15(1):20-7. PubMed ID: 9050136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer and leukemia group B breast committee: decades of progress and plans for the future.
    Hudis CA; Winer EP
    Clin Cancer Res; 2006 Jun; 12(11 Pt 2):3576s-80s. PubMed ID: 16740788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
    Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
    Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
    [No Abstract]   [Full Text] [Related]  

  • 12. Pegfilgrastim: evidence in support of its use with cytotoxic chemotherapy.
    Ng R; Green MD
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):585-90. PubMed ID: 16111460
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.